Last 9 Pamidronate MDL Plaintiffs Give Up In Face Of Generic Preemption Case Law

BROOKLYN, NY - The New York federal judge overseeing the pamidronate multidistrict litigation on Jan. 30 dismissed the claims of the last nine plaintiffs in the litigation after they did not oppose a finding that their claims involving the generic version of Aredia are preempted by the U.S. Supreme Court's generic preemption ruling in Pliva, Inc. v. Mensing (131 S.Ct. 2567 [2011]) (In Re: Pamidronate Products Liability Litigation, MDL Docket No. 2120, No. 1:09-md-2120; John Bartoli, et al. v. APP Pharmaceuticals, Inc., et al., No. 10-1860, E.D. N.Y.). Full story on lexis.com